Edgewise Therapeutics(EWTX)
BOULDER, COBiotechnology
Focus: Edgewise Therapeutics is a public biotech company focused on small-molecule therapeutics for musculoskeletal diseases, particularly muscular dystrophies. Listed on NASDAQ (EWTX), the company operates from Boulder, Colorado with a specialized pipeline targeting rare genetic muscle disorders.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
13+13 this month
Growing — net +13 jobs in 30d
13 jobs added vs 0 removed. Steady team buildout.
Should You Work at Edgewise Therapeutics?
AI assessmentEdgewise offers focused muscular dystrophy expertise and recent acquisition validation, but early-stage pipeline depth and cash burn create near-term career volatility; best fit for scientists willing to ride through acquisition integration.
Why Work Here
- Lead scientist or clinical development role on sevasemten, a Phase 2 program in both Duchenne and Becker muscular dystrophy with multiple active trials demonstrating clinical traction.
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
18 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Defining Endpoints in Becker Muscular Dystrophy
Becker Muscular DystrophyClinical Trials (1)
NCT05257473Defining Endpoints in Becker Muscular Dystrophy
N/AHelp build intelligence for Edgewise Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.